David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Ormat Technologies
ORA
$6.48B
| $14.7M | 0.01% |
175,862
+119,501
| +212% | +$8.93M |
|
1152
Sabra Healthcare REIT
SBRA
$5.23B
| $14.7M | 0.01% |
797,050
+491,131
| +161% | +$8.72M |
|
1153
CALL
TC Energy
TRP
$64.7B
| $14.7M | 0.01% |
300,000
+200,000
| +200% | +$9.82M |
|
|
AVNS
1154
DELISTED
Avanos Medical
AVNS
| $14.6M | 0.01% |
1,191,922
+102,947
| +9% | +$1.29M |
|
1155
PUT
Toast
TOST
$21.2B
| $14.6M | 0.01% |
328,900
-7,000
| -2% | -$275K |
|
1156
First Industrial Realty Trust
FR
$8.41B
| $14.5M | 0.01% |
301,738
-282,172
| -48% | -$13.8M |
|
1157
California Resources
CRC
$4.65B
| $14.5M | 0.01% |
317,490
+43,851
| +16% | +$1.79M |
|
1158
PUT
STMicroelectronics
STM
$44B
| $14.5M | 0.01% |
476,500
-233,800
| -33% | -$5.8M |
|
1159
BJs Wholesale Club
BJ
$12.6B
| $14.5M | 0.01% |
134,312
+93,445
| +229% | +$10.6M |
|
1160
Alpha Metallurgical Resources
AMR
$2.66B
| $14.4M | 0.01% |
128,422
+64,804
| +102% | +$7.57M |
|
1161
Innospec
IOSP
$2.33B
| $14.4M | 0.01% |
171,738
+72,662
| +73% | +$6.36M |
|
1162
IDEX
IEX
$17.2B
| $14.4M | 0.01% |
+82,111
| New | +$14.6M |
|
1163
Fox Factory Holding Corp
FOXF
$910M
| $14.4M | 0.01% |
555,554
-304,448
| -35% | -$7.13M |
|
1164
Bloomin' Brands
BLMN
$980M
| $14.3M | 0.01% |
1,665,323
+848,904
| +104% | +$6.82M |
|
1165
Akamai
AKAM
$15.2B
| $14.3M | 0.01% |
179,604
+162,238
| +934% | +$12.6M |
|
1166
Laureate Education
LAUR
$5.14B
| $14.3M | 0.01% |
611,042
+113,746
| +23% | +$2.44M |
|
1167
CALL
Cigna
CI
$74.1B
| $14.2M | 0.01% |
43,100
+3,500
| +9% | +$1.13M |
|
1168
Viavi Solutions
VIAV
$9.12B
| $14.2M | 0.01% |
1,414,293
+65,400
| +5% | +$632K |
|
1169
TAL Education Group
TAL
$6.37B
| $14.2M | 0.01% |
1,390,007
+409,460
| +42% | +$4.23M |
|
1170
Bath & Body Works
BBWI
$3.86B
| $14.2M | 0.01% |
+472,726
| New | +$13.8M |
|
1171
Boise Cascade
BCC
$2.87B
| $14.1M | 0.01% |
162,853
+30,624
| +23% | +$2.78M |
|
|
DVAX
1172
DELISTED
Dynavax Technologies
DVAX
| $14.1M | 0.01% |
1,424,364
-1,062,388
| -43% | -$11.2M |
|
1173
Southern Copper
SCCO
$181B
| $14.1M | 0.01% |
146,342
-199,347
| -58% | -$17.3M |
|
1174
Lumen
LUMN
$5.85B
| $14.1M | 0.01% |
3,208,041
-4,248,889
| -57% | -$16.5M |
|
|
VLOS
1175
Velos Acquisition I Corp
VLOS
$252M
| $14M | 0.01% |
1,237,500
| – | – |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.